Sarcopenia

Journal of Laboratory and Clinical Medicine

Volumn 137, Issue 4, 2001, Pages 231-243

  Morley, John E ^a,b,c,d   Baumgartner, Richard N ^a,b,c,d   Roubenoff, Ronenn ^a,b,c,d   Mayer, Jean ^a,b,c,d   Nair, K Sreekumaran ^a,b,c,d  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035073967     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.113504     Document Type: Article

References (124)

1. The aging of America: Impact on health care costs
2. Disability as a public health outcome in the aging population
3. Muscle mass and strength: Relation to function in population studies
4. Appendicular skeletal muscle mass: Effects of age, gender and ethnicity
5. Cross-sectional age differences in body composition in persons 60+ years of age
6. Human body composition and the epidemiology of chronic disease
7. Assessment of nutritional status in the aged
8. Muscle wasting in the elderly
9. Body mass index, weight change, and risk of mobility disability in middle-aged and older women: The Epidemiologic Follow-up Study of NHANES I
10. Genetic determinism of fiber-type proportion in human skeletal muscle
11. Correlates of impaired function in older women
12. Epidemiology of sarcopenia in elderly people in New Mexico
13. Skeletal muscle mass: Evaluation of neutron activation and dual energy X-ray absorptiometry methods
14. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups
15. Predictors of skeletal muscle mass in elderly men and women
16. Age-related changes in muscle
17. Age and gender comparisons of muscle strength in 654 women and men aged 20-93 years
18. Regulation of muscle mass and function: Effects of aging and hormones
19. Human aging, muscle mass, and fiber type composition
20. Association of muscle power with functional status in community-dwelling elderly women
21. Muscle performance and structure in the elderly as studied cross-sectionally and longitudinally
22. Compensatory muscle fiber hypertrophy in elderly men
23. The effect of age on protein metabolism: Current opinion
24. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart
25. Effect of age on in vivo synthesis rates of mitochondrial protein in human skeletal muscle
26. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans
27. Increase in the degree of coexpression of myosin heavy chain isoforms in skeletal muscle fibers of the very old
28. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: A clinical research center study
29. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
30. Effect of growth hormone and resistance exercise on muscle growth and strength in older men
31. Myofibrillar protein synthesis in young and old human subjects after three months of progressive resistance training
32. Motor units in old age
33. The effects of ageing upon the human soleus muscle. An electrophysiological study
34. Changes in motor unit estimates with aging
35. The effect of age on neuromuscular transmission
36. Skeletal muscle weakness in old age: Underlying mechanisms
37. Effects of aging on motor-unit control properties
38. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins
39. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins
40. Involvement of interleukin-6 in activation of lysosomal cathepsin and atrophy of muscle fibers induced by intramuscular injection of turpentine oil in mice
41. The acute metabolic effects of tumor necrosis factor administration in humans
42. Biological basis for interleukin-1 in disease
43. Rheumatoid cachexia: Cytokine-driven hypermetabolism and loss of lean body mass in chronic inflammation
44. Standardization of nomenclature of body composition in weight loss
45. Monocyte cytokine production in an elderly population: Effect of age and inflammation
46. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
47. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
48. Anorexia of aging: Physiologic and pathologic
49. Neuropeptide regulation of appetite and weight
50. Anorexia and aging: Pathophysiology
51. Inhibition of feeding by a nitric oxide synthase inhibitor: Effects of aging
52. Relation between postprandial satiation and antral area in normal subjects
53. Effects of age on concentrations of plasma cholecystokinin, glucagons-like peptide 1, and peptide YY and their relation to appetite and pyloric motility
54. Effect of gastrointestinal peptides on ingestion in old and young mice
55. Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age
56. Leptin, adipose tissue and aging: Is there a role for testosterone?
57. Evidence for leptin regulation of food intake in humans
58. Body composition and age in African-American and caucasian women: Relationship to plasma leptin levels
59. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat
60. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial
61. The effects of aging on opioid modulation of feeding in rats
62. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats
63. Pathophysiology of catabolism in undernourished elderly patients
64. Systemic administration of ciliary neurotrophic factor induces cachexia in rodents
65. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
66. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations
67. Wasting in cancer
68. Prevalence and causes of undernutrition in medical outpatients
69. Causes of weight loss in a community nursing home
70. Factors associated with low body mass index and weight loss in nursing home residents
71. Depression
72. Anorexia in older persons: Epidemiology and optimal treatment
73. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
74. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur
75. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial
76. Nutritional support and aging in preoperative nutrition
77. Does artificial enteral nutrition prolong the survival of institutionalized elders with chewing and swallowing problems?
78. Total parenteral nutrition in the critically ill patient: A meta-analysis
79. Malnutrition in the elderly. Is it simply a matter of not eating enough?
80. Anabolic effects of nandrolone decanoate in patients receiving dialysis: A randomized controlled trial
81. Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients
82. Single-agent/combination therapy of human immunodeficiency virus-related wasting
83. Approach to the seriously ill or terminal cancer patient who has a poor appetite
84. Geriatric cachexia: The role of cytokines
85. The effect of recombinant human growth hormone on malnourished older individuals
86. Inceased mortality associated with growth hormone treatment in critically ill adults
87. Exercise strategies should be designed to increase muscle power
88. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentrations
89. Homocysteinemia as a risk factor for atherosclerosis: A review
90. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
91. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy
92. Vitamins for the management of cardiovascular disease: A simple solution to a complex problem?
93. Homocysteine
94. Acute creatine supplementation in older men
95. Effects of 30 days of creatine ingestion in older men
96. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
97. Secondary hypogonadism in older men: Its relation to impotence
98. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone
99. Testosterone and leptin in older African-American men: Relationship to age, strength, function, and season
100. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age
101. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study
102. Effects of testosterone and growth hormone on muscle function
103. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women
104. The somatopause: Should growth hormone deficiency in older people be treated?
105. Hormonal fountains of youth
106. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback
107. Exercise strategies should be designed to increase muscle power
108. A 20-year longitudinal study of Olympic oarsmen
109. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures: A randomized controlled trial
110. A walking program improves gait and balance in nursing home patients
111. A longitudinal trial of weight training in the elderly: Continued improvements in year 2
112. Effects of strength training and detraining on muscle quality: Age and gender comparisons
113. Changes in power with resistance training in older and younger men and women
114. Maximal power across the lifespan
115. Effects of high-intensity resistance training on untrained older men. I. Strength, cardiovascular, and metabolic responses
116. Effects of high-intensity resistance training on untrained older men. II. Muscle fiber characteristics and nucleo-cytoplasmic relationships
117. Changes in muscle morphology, electromyographic activity, and force production characteristics during progressive strength training in young and older men
118. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men ≥76 yr old
119. Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78-84 and 23-32 yr olds
120. Self-paced resistance training and walking exercise in community-dwelling older adults: Effects on neuromotor performance
121. Exercise training and nutritional supplementation for physical frailty in very elderly people